Molecular oxygen is involved in the oxidation of substrates used to produce energy; however, normal metabolism can also generate harmful (bio)chemical byproducts. These deleterious products are partially reduced forms of oxygen, and include free radicals such as superoxide anion radical, hydroxyl radical, or highly oxidizing non-radical species such as hydrogen peroxide (H2O2) and lipid peroxides, which are collectively known as ROS. 1 ROS typically derive from normal metabolism, activated leukocytes, and ambient oxygen in the environment. The production and accumulation of ROS and their downstream effects can be controlled or attenuated by antioxidants. When the ability of antioxidants to eliminate harmful cellular and extracellular ROS is compromised, the balance between ROS generation and antioxidant function to eliminate ROS is shifted in favor of an accumulation of oxidants, which defines the state of oxidative stress in a cell or organism. Oxidative damage can affect DNA, lipids, and proteins, and eventually compromise cell integrity. Many studies have implicated ROS in the pathological processes leading to heart disease, cancer, aging, AIDS, and inflammatory and autoimmune diseases.
mitochondrial SOD (Mn 2+ SOD or SOD 2), and extracellularly, by EC-SOD (EC-SOD or SOD 3). Extracellular ROS may also accumulate as a consequence of cell-surface receptor -ligand interactions that lead to the direct generation of H2O2. 8 The flux of H2O2 from the intracellular compartment to the extracellular compartment is believed to occur predominantly by free diffusion through the lipid bilayer; however, recent data suggest that membrane channels, such as the aquaporins (AQP), can transport not only water, but also other small, uncharged molecules, such as NO and H2O2. A screen of AQP isoforms in yeast identified 3 specific AQPs that facilitated H2O2 transport across membranes: 1 of these was a human form of AQP, hAQP8, and the others, plant forms, AtTIP1;1 and AtTIP1;2. 9
Consequences of ROS in the Extracellular Environment
The major consequences of oxidative stress in the extracellular environment are lipid peroxidation and oxidative protein modification, which may alter cellular integrity and affect cell signaling. Lipid peroxidation is manifest in atherosclerosis, in which oxidized low-density lipoprotein (LDL) is associated with endothelial dysfunction and injury. 10 ROS can cause a broad range of oxidative modification of proteins, not only at reactive cysteines (Cys), but also at methionyl, lysyl and arginyl residues. Most widely studied are the oxidative modifications of cysteinyl residues. Specifically, the cysteinyl residues of many proteins participate in reversible oxidation reactions leading to the formation of thiolates
(-S -), thiyl radical (-S · ), disulfides (-S-S-), disulfide-S-mono-and di-oxides (-S-(O)-S-or S-(O2)-S-)
, selenosulfides (-Se-S-), and sulfenic acid (-SOH). 11, 12 Hyperoxidation of Cys residues can lead to irreversible formation of sulfinic acid (-SO2H) and sulfonic acid (-SO3H). 11 In addition, protein thiols can react to form mixed disulfides with extracellular GSH (S-glutathiolation) or other small thiols, or to form S-nitrosthiol derivatives (RSNO). 11, 12 There are a variety of roles that NO plays in protein modification, such as N-nitrosation, S-nitrosation, and higher order oxidation of thiols. 13 Initial measurements of S-nitrosothiols in plasma reported levels of approximately 7 mol/L for NO present as RSNO, compared with free NO levels of 3 nmol/L. 14 Most RSNO is reported to exist primarily as an S-nitroso adduct to albumin. 14, 15 Recent studies have suggested lower levels of plasma RSNO, in the nanomolar range, although it has been confirmed that S-nitrosated albumin is the major circulating RSNO species. 16 Once believed to be only a harmful metabolite, the role of H2O2 is now viewed in terms of threshold ROS concentration; that is, serving a dual role as a source of oxidant stress at high concentration (>100-200 mol/L), and also as a signaling molecule central to many well-known signaling pathways at low concentrations (<100-200 mol/L). In addition, De Yulia et al showed that generation of extracellular H2O2 by receptor -ligand interaction is involved in cell signaling independent of enzymatic intracellular H2O2 generation. 8 Specifically, those authors showed that extracellular catalase attenuated EGF-stimulated EGFR phosphorylation, 8 suggesting that extracellular H2O2 generated during receptor-ligand binding was essential for EGFR activation and subsequent signal transduction.
Other evidence suggests H2O2 may play an important role in regulating vascular function. In cultured cells, Rao et al found that H2O2 stimulated smooth muscle cell (SMC) proliferation, but decreased DNA synthesis in endothelial cells. 17 H2O2 has been also shown to regulate vascular tone. In some vascular beds, H2O2 may induce contraction, whereas in others it induces relaxation. It has been suggested that differences in the K + channel and/or Ca 2+ handling in various vascular beds or under different conditions may mediate these diverse actions of H2O2. In hypertensive rats, there is an increase in H2O2-induced contraction in arteries but not in veins, 18 and plasma H2O2 levels have been shown to correlate with mean arterial pressure in hypertensive patients. Overall, these findings suggest a role of ROS in vascular function and blood pressure regulation. 19, 20 
Extracellular Proteins and the Extracelluar Environment
Disulfide bonds are essential for the activity of many extracellular proteins, and are found in membrane proteins, as well as in secreted extracellular proteins, generated or maintained primarily because of the oxidizing environment of the extracellular compartment. 21 Disulfide bonds are formed by thiol -disulfide exchange reactions, and serve to stabilize the correctly folded extracellular protein, thereby maintaining its structure and function. Mixed disulfides can also form between protein cysteinyl residues and extracellular GSH, as well as between cysteinyl residues of different proteins.
Experiments performed in our laboratory recently revealed that mitochondria play a key role in disulfide bond formation. Specifically, ROS generated by mitochondria were found to facilitate cell-surface disulfide formation, and suppressing ROS generation with mitochondrial electron transport inhibitors decreased global disulfide bond formation, as well as disulfides, in a subclass of extracellular proteins. These alternations in the disulfide bonds altered the cellular location of some receptor proteins, including endoglin. 22 Furthermore, extracellular protein disulfides were found to comprise 2 subclasses: those regulating the structural integrity of the protein, and those redox-sensitive disulfides that form reversibly, and by so doing, are involved in regulating cell signaling.
NO Transport and Thiol Modification
NO may also have an important role in altering redoxsensitive thiols in the intracellular and extracellular environments. Recent work suggests transport of NO is facilitated by AQPs. AQP-1 is found in many cells in which NO exerts its physiological functions, such as in endothelial cells. In a study by Herrera et al, AQP-1 was shown to be important for NO transport, because the flux of NO from the endothelial cells was reduced when AQP-1 was inhibited by dimethyl sulfoxide and HgCl2, or when AQP-1 expression was diminished by siRNA knockdown. 23 Those data suggest that AQP-1 plays an important role in NO influx and efflux from endothelial cells, and may, therefore, regulate the extracellular effects of NO. Recently, a study published by the same group 24 examined aortic rings from AQP-1 -/-mice. NO efflux from endothelial cells and influx into SMC were decreased in that model. In endothelium-denuded aortic rings, an exogenous NO donor was unable to cause vasorelaxation, suggesting AQP-1 also contributed to the influx of NO into SMC. The study demonstrated that facilitated transport of NO in vascular cells is essential for its vasorelaxing effects to be manifest.
NO also leads to S-nitrosation of protein thiols that can exert intracellular signaling effects, and represents a major form of post-translational modification. 25 NO modification of proteins can involve many protein types, such as channels, transporters, kinases, phosphatases, signaling molecules, structural molecules, and redox enzymes, to name a few. 26 In addition, low-molecular-weight RSNO have also been shown to diffuse into cells aided by cell surface receptors. Studies by our group and others demonstrate that protein disulfide isomerase (PDI) at the plasma membrane helps to mediate transnitrosation and intracellular NO release by extracellular low-molecular-weight RSNO. 27, 28 Low-molecular-weight RSNO have also been demonstrated to accumulate intracellularly following the addition of an exogenous RSNO donor source or after activation of endogenous NO synthase. 29 Extracellular levels of RSNO can also influence intracellular thiol levels by the transport of a low-molecular-weight RSNO, thus representing a different method of RSNO influx independent of NO generation. 30 
Low-Molecular-Weight Extracellular Antioxidants

Glutathione (GSH)
GSH is a key low-molecular-weight thiol found in both the intracellular and extracellular environments. This tripeptide of serine, Cys and glutamate serves to maintain the redox integrity of the cell in a reduced state and combats oxidative stress. 31 Abundant in the cytosol and found in the mitochondria and nuclei, GSH can form disulfide bonds with other molecules bearing thiol functionalities. The Cys of GSH allows it to participate in cellular redox reactions by acting as a nucleophile when in the thiolate form, whereas higher oxidation states of this amino acid adversely affect protein function. 11 GSH serves as a natural intracellular thiol redox buffer, maintaining the intracellular environment in a reduced state. The ratio of reduced-to-oxidized GSH (GSH/GSSG) is typically 50:1 in the cytosol of most cells; in the endoplasmic reticulum (ER), it is 2:1. Thus, the more oxidizing conditions in the ER permit disulfide bond formation, which is largely catalyzed by PDI. 32 Recent work from our group, however, has challenged this concept somewhat, with the observation that disulfides also form in the Golgi. 22 Importantly, GSSG is recycled to GSH by GR, which uses NADPH as the electron source.
Although the intracellular levels of GSH remain high, it may also play a role extracellularly. GSH is found at approximately 0.001-fold the concentration in plasma (2.8 mol/L) compared with the intracellular compartment (3-10 mmol/L). 33 Intracellular GSH serves a protective role in many disorders such as Parkinson's disease, cystic fibrosis, cancer, and neurogenerative disease, and also in HIV and aging. 34 An increased level of blood GSH has been shown to be an independent predictor of lipid peroxidation in congestive heart failure patients. The significance of this change is unclear; however, it may indicate decreased (extracellular) GPx-3 activity, secondary to severe renal dysfunction in heart failure, as the kidney is the principal source of GPx-3. 35 Glutathiolation is a reversible posttranslational modification that occurs by direct interaction of protein-SH with GSH under oxidizing conditions, by thiol disulfide exchange between a protein-SH and GSSG, or by reaction of protein-SH with S-nitrosoglutathione. 36 To date, no specific glutathiolated plasma proteins have been reported; however, glutathiolation has been demonstrated for the intracellular forms of 1-Cys peroxiredoxins (Prx), Trxs, and Grxs and other cellular proteins, 37, 38 such as RAS and SERCA. [39] [40] [41] 
Cysteine (Cys)
Free L-Cys is the major extracellular thiol. The major oxidized form, cystine (Cyss), exists predominantly in plasma and, thus, the Cys/Cyss ratio is used as a measure of the extracellular redox state. Oxidized Cys, Cyss, has been found to be approximately 120 mol/L in plasma of healthy adults. 42 L-Cys serves as a precursor to GSH formation in cells, and there appears to be a balance between intra-and extracellular Cys levels that may also affect GSH levels. 43 One report found that when Cys is omitted from the media, erythrocytes compensate by a net efflux of Cys into the media, whereas when extracellular Cys levels are high, there is a net influx of Cys into erythrocytes. 43 Low concentrations of Cys in plasma can be easily oxidized, suggesting that influx and efflux of the reduced Cys may contribute to plasma redox status, and help to keep the oxidized form at low concentrations. In addition, rats fed diets deficient in this amino acid showed compromised plasma Cys/Cyss and GSH/GSSG redox ratios, and an increase in Cyss and GSSG, compared with rats fed diets supplemented with adequate Cys 44 The crosstalk between these redox pairs was also demonstrated in mice with a knockdown of a Cys/glutamate transporter: these mice exhibited increased Cyss and low GSH levels. 45 It has been suggested that the extracellular thiol/disulfide redox state may predict cardiovascular events. [46] [47] [48] In a study of healthy adults, the redox state of GSH/GSSG was found to be an independent predictor of intima -media thickness, an early measure of atherosclerosis. 47 Other studies in cultured cells found that highly oxidized Cys/Cyss mixtures can increase the expression of adhesion molecules, cause nuclear factor B (NF B) activation, and promote H2O2 generation, suggesting extracellular redox conditions can promote a proatherogenic state. An increase in adhesion molecule expression by endothelial cells is considered an early indicator of atherosclerosis. 48 
Glutaredoxins (Grx)
Grxs, or thioltransferases, are part of the family of thiol disulfide oxidoreductases with a strong preference for reducing GSH mixed disulfides. Grx was identified in Escherichia coli (E. coli) as a hydrogen donor for ribonucleotide reductase. 49 These small thiol proteins contain a C-X-X-C conserved sequence in their active sites, which is part of the Trx fold. 50, 51 Two Grx have been found in humans, Grx1, a cytosolic protein, and Grx2, a mitochondrial isoform. 52, 53 To date, Grx 1-3 have been identified in E. coli, 54, 55 whereas Grx3-5 have been identified in Saccharomyces cerevisiae; 56, 57 Grx1 and 2 have also been detected in human plasma. 58 Studies indicate that the human Grx gene is transcriptionally regulated by oxidative stress 59 via activation of AP-1. 60 Grx are small 11-kDa molecules that are part of the GR/Grx system, which consists of GSH and an NADPHdependent GR, where NADPH acts as a source of reducing equivalents for the recycling reduction of GSH. These antioxidant proteins engage in dithiol and monothiol catalyzed reactions, 61, 62 and, thus, their targets are mixed disulfides comprising a protein cysteinyl residue and a disulfide-linked glutathionyl residue, as well as protein disulfides. 63 Grx reduces glutathiolated proteins and, in turn, is reduced by GSH: 64 protein-S2 + 2 GrxSHred 2 protein-SH + 2 GrxSoxd (1) 2 GrxSoxd + 2 GSH 2 GrxSHred + GSSG (2) Recently, the selenoprotein translational cofactor selenocysteine insertion sequence (SECIS) binding protein 2 (SBP2) has been shown to be reduced by Grx or Trx, at least in in vitro assays, 65 suggesting that thiol -disulfide oxidoreductases may modulate the synthesis of extracellular selenoproteins, such as GPx-3 and selenoprotein P (Sel P), during oxidative stress.
Evidence suggests a role for Grx in redox regulation, at least intracellularly, where Grx may play an important role in maintaining the reduced state of thiols. Grx has an antiapoptotic effect, as well, which involves regulating the redox status of Akt; 66 Grx binding to the apoptosis signal regulating kinase may also modulate apoptosis. 67, 68 Grx has also been found to play a role in diverse processes, such as insulin secretion 69 and restoring the function of oxidized transcription factor nuclear protein 1. 70 Under oxidative stress, Grx levels increased in human coronary artery SMC, suggesting a protective role. 71 The role of Grx in extracellular fluid is not yet determined, but it may play an important role in antioxidant defense. Human Grx has been found in extracellular fluids, and is present at high concentrations in the sputum of patients with chronic obstructive pulmonary disease. 72 The extracellular concentration of Grx is approximately 2 nmol/L and has also been detected in the plasma of healthy volunteers at approximately 13.4 ng/ml, 58, 73 where it may serve as an electron donor for the major extracellular antioxidant enzyme GPx-3. 74 Grx may also work in concert with Trx and GSH to regulate (extracellular) redox signaling.
Thioredoxin (Trx)
Trx is a small 12-kDa redox-active protein, and contains a conserved W-C-G-P-C sequence at its active site. 75 Its oxidoreductase function accounts for its involvement in the formation, reduction, or isomerization of disulfide bonds. Trxs are ubiquitous and mostly reduce cytoplasmic protein Cys residues. Trx is also important in a variety of redox reactions, such as reversible oxidation of proteins, reduction of hydroperoxides, and redox regulation of cell growth, transcription factors, and apoptosis, 76,77 some of which occur in the extracellular compartment. Similar to the Grx system, the Trx/TrxR system plays a major role as an antioxidant and may also play a significant role in decreasing ROS species extracellularly. In the presence of TrxR, oxidized Trx is reduced at the expense of NADPH:
Reduced Trx can then reduce protein disulfides, generating oxidized Trx: 62 Protein-S2 + Trx-(SH)2 protein-(SH)2 + Trx-S2 (
There are many well-known substrates for the disulfide reductase activity of Trx, including ribonucleotide reductase, Prx, methionine sulfoxide reductase, phosphatases and transcription factors. 78 Trx may also serve as an electron donor for the potential peroxidase activity of albumin, 79 mediate the reduction of the annexin A2-S100A10 homotetramer that is oxidized by plasmin, 80 and regulate the redox state of SBP2. 65 Two major forms of Trx have been identified: Trx1, a cytosolic from, and Trx2, a mitochondrial form. Trx-related protein 14 has also been shown to have similar disulfide reductive properties as Trx1, but seems to exhibit less activity with many of the known Trx substrates. 78 One form found in the plasma of healthy blood donors is a truncated form of Trx1 that contains 80 amino-terminal residues, Trx80. Trx80 was reported to have mitogenic cytokine activity in normal, resting, human blood mononuclear cells, but lacked redox activity. 81 Trx interacting protein (TXNIP) is known to inhibit Trx activity when bound to the protein. Critical cysteinyl residues have been shown to be important for TXNIP disulfide bond interaction, lending support to its role as a redox-active protein. 82 Its release from Trx increases Trx activity. At this time, there are no known reports of TXNIP interacting with extracellular Trx; intracellularly, TXNIP may act a signaling molecule. The release of TXNIP from Trx can also be modulated by NO. 83 Originally thought to be a predominantly intracellular protein, Trx also has extracellular roles. Cloning of the human Trx gene has not revealed the presence of a signal sequence, as would typically exist for secreted proteins; 75 however, it may be secreted by a non-classical pathway. 84, 85 Full-length and truncated Trx (Trx80) have been detected in plasma and may provide further clues to its other role as a secretory antioxidant protein. Both the long and truncated forms of the protein have been localized to the cell surface, and it has been suggested to have an antioxidant role in the extracellular environment. 86 Plasma levels of Trx have been shown to correlate with oxidative stress. 73, 87 Intracellularly, Trx levels are in the 0.1-2 mol/L range, and extracellularly, in the 1-5 nmol/L range. [88] [89] [90] In human plasma, Trx has been found at a concentration of 30 ng/ml, using sandwich ELISA. 81 Circulating Trx levels have been shown to be altered in several disease states, such as AIDS, heart failure, angina, myocardial infarction, lung inflammation, diabetes mellitus, and cancer. 89, [91] [92] [93] [94] [95] [96] [97] Trx is also expressed in endothelial cells and vascular SMC (VSMC). 71 Although Trx may be considered an antioxidant, secreted Trx may play role in the severity of heart failure, 98 and Trx levels have been correlated with increased platelet aggregability in patients with myocardial infarction, compared with patients with stable angina and chest pain syndrome. 89 Secreted Trx and truncated Trx80 have cytokine-and chemokine-like properties. 81, 99 In cell culture systems, extracellular recombinant Trx1 has been shown to modulate inflammatory responses, 100 because the addition of recombinant Trx to lipopolysaccharide-activated human monocytederived macrophages decreased interleukin (IL)-1 mRNA expression and NF B activation. 100 Other roles of Trx in inflammation are induction of the cytokines IL-6 and IL-8. In rheumatoid arthritis, Trx is significantly increased in synovial fluid and in cultured synovial fibroblasts, and potentiates the induction of cytokines IL-6 and IL-8 by tumor necrosis factor . 90, 101 In addition, in patients with acute lung injury, Trx and IL-8 are elevated in plasma and bronchoalveolar lavage fluid.
Full-length Trx and truncated Trx80 are chemotactic molecules for monocytes, neutrophils, and T cells. 102 Chemotactic properties, at least for the full-length Trx, require redox-active cysteinyl residues, as mutation of cysteinyl residues in the protein results in loss of chemotactic activity. 103 The activity of Trx as a chemotactic agent in vivo is unclear because other studies have found Trx can prevent neutrophil migration. 91 Trx also prevents the chemotactic response in peripheral arterial disease, where it has been proposed to play a role in attenuating reperfusion injury (after angioplasty). 104 Other work has identified Trx as a secreted molecule from a CD4 + T cell line, where its secretion can be induced by cytokines. 105 Other studies have found Trx expression is upregulated in response to oxidative stress. [106] [107] [108] Trx also functions as a growth factor and inhibits apoptosis. 109 In contrast to its chemotactic properties, the mitogenic properties of Trx may not require cysteinyl residues, at least for the Trx80 isoform. 81 It has also been suggested that Trx promotes cell growth in cancer. 96, 110 
Extracellular Antioxidant Enzymes Extracellular Superoxide Dismutases (EC-SOD)
SODs are major antioxidant enzymes that protect cells and organisms from the damaging effects of superoxide anion. SODs catalyze the dismutation of superoxide, 2O2 ·-+ 2H + O2 + H2O2; it has been shown to be a second-order reaction with a rate constant of 2.3 × 10 9 ·M -1 ·S -1 . 111 This rate constant is approximately 10,000 times faster than the spontaneous dismutation of O2 ·-. 112, 113 SODs work in conjunction with catalase and peroxidases to diminish the harmful effects of ROS. In addition to EC-SOD, 2 other known SODs exist: an intracellular form, Cu 2+ /Zn 2+ SOD, and a mitochondrial form, Mn 2+ SOD.
EC-SOD is a 30-kDa tetrameric protein 114 found in most tissues, including blood vessels, heart, lungs, kidney, and placenta; 115 however, higher amounts of EC-SOD are present in vascular tissue. 116 The source of vascular EC-SOD is largely VSMC. Once secreted, EC-SOD localizes to the glycosaminoglycan-containing extracellular glycocalyx. Oxidants apparently do not drastically change transcription of EC-SOD. 116 Although EC-SOD is predominantly a homotetrameric protein, in the human aorta it can also exist in an octameric form. 117 Catalytic activity requires Cu 2+ and Zn 2+ bound to each subunit. Due et al have also shown that EC-SOD is composed of folding variants, aEC-SOD and iEC-SOD, that contain active and inactive enzymatic subunits, respectively.
EC-SOD also contains a heparin-binding domain located in the carboxyterminal region of the protein. 115 Possible roles for this domain include functioning as a nuclear localization signal and an association with heparan sulfate glycosaminoglycans in the endothelial glycocalyx. 118 Cleavage of the heparin-binding domain may be an important regulatory mechanism in the extracellular environment. Isolation of EC-SOD on heparin-Sepharose columns revealed 3 fractions that relate to different heparin-binding affinities. A study of EC-SOD activity in rats has shown that it is sensitive to dietary Cu 2+ , but not Zn 2+ , and that its activity may be an indicator of Cu 2+ status. Unlike the human EC-SOD, rat SOD exists as a dimer and has a poor affinity for heparin, which may explain the higher concentration found in rat plasma compared with human plasma. 119 EC-SOD has also been implicated in the antioxidant defense of hamsters after arousal from hibernation, during which reperfusion accompanying the increase in cardiac output leads to a state of transient oxidant stress. 120 The different affinities of EC-SOD may regulate its cellular distribution and its function. Not only may EC-SOD act extracellularly, but it may also act intracellularly, requiring the heparin-binding domain to gain access to the cell. Chu et al compared the cellular localization of a common genetic variant, EC-SODR213G, which has a mutation in the heparin-binding domain, to wild-type EC-SOD and to EC-SOD with a deleted heparin-binding domain, EC-SOD∆HBD. They demonstrated that when these 3 exogenous EC-SOD forms were incubated with cells, only the wild-type form entered mouse endothelial cells via endocytosis, 121 indicating that an intact heparin-binding domain is necessary for internalization. The heparin-binding domain variant was also shown to provide little protection from oxidative stress in humans, 122 and elevated plasma levels of this variant were associated with increased risk of ischemic heart disease, compared with the 142 ng/ml of plasma EC-SOD in non-carriers. 123 It is well established that EC-SOD is a major extracellular antioxidant. A study of the overexpression of EC-SOD in human fibroblasts demonstrated that not only did EC-SOD activity protect against oxidative stress, but it also prevented telomere shortening and increased the lifespan of cells exposed to oxidant stress. 124 Pulmonary EC-SOD expression and activity have been shown to be affected by hypoxia, 125, 126 and EC-SOD is also elevated during inflammation in the lung. 127, 128 EC-SOD also has an important role in modulating NO bioavailability and vascular tone. In animal models of angiotensin II (AII)-induced hypertension, EC-SOD expression increases, possibly to attenuate the hypertensive response, by preserving endothelial function; 129 however, studies in EC-SOD knockout mice (EC-SOD -/-) show a complex relationship between EC-SOD and other antioxidant enzymes that protect vascular function. 130 Although detectable, intracellular and extracellular superoxide levels were higher in EC-SOD -/-mice, these mice also had unexpectedly preserved endothelial function in mesenteric arteries, even after AII-induced hypertension. Similarly, aortic rings from these mice treated with AII showed an increase in NO production compared with aortic rings from non-hypertensive EC-SOD -/-mice. Conversely, superoxide production increased in wild-type vessels from AII-treated mice, whereas it decreased in vessels from AII-treated EC-SOD -/-mice. In that study, there was a corresponding increase in intracellular SOD expression and a decrease in Nox in the EC-SOD -/-mice following AII treatment, which may partially explain these results. The findings suggest a feedback mechanism between intra-and extracellular antioxidant enzymes that influences the flux of ROS in and out of the cell.
Other studies show that H2O2 and ONOO -can both decrease EC-SOD and intracellular Cu 2+ /Zu 2+ SOD activity, 131 providing evidence that ROS can modulate these antioxidant enzymes. In the 1-kidney 1-clip model of hypertension, aortic superoxide was elevated over basal levels in both wild-type and EC-SOD -/-mice, and recombinant EC-SOD lowered blood pressure and improved aortic NO bioavailablity in both types of mice. 131 Those data suggest that oxidant production can inactivate endogenous SOD, contributing to vascular dysfunction, decreased NO bioavailability, and hypertension.
In human studies, plasma EC-SOD is diminished in African -American hypertensive patients 132 and in patients with stable angina. 133 EC-SOD activities were also diminished in healthy individuals with advancing age in whom decreased EC-SOD activity correlates with decreased plasma levels of nitrite/nitrate, suggesting that an impairment in antioxidant activity may reduce NO bioavailability. 134, 135 Extracellular Catalase (Cat) Cat catalyzes the reduction of H2O2 generated by SOD to water and molecular oxygen: 2 H2O2 O2 + 2 H2O.
Its catalytic efficiency is at the diffusion limit of H2O2, and is said to be close to "catalytic perfection". Like the GPx's, Cat reduces H2O2; however, unlike the GPx's, it does not reduce lipid peroxides and does not require reducing cofactors.
Cat is viewed principally as an intracellular antioxidant protein localized primarily in the peroxisomes. Its enzymatic efficiency compares favorably with the rate of H2O2 diffusability through membranes, allowing Cat to decrease H2O2 flux substantially to the extracellular environment. In this way, intracellular Cat affects extracellular H2O2 and the accompanying oxidative stress.
In bacteria, extracellular Cat with peroxidase-like characteristics has been isolated. 136 A 60-kDa extracellular Cat has also been found in the medium of CCRF-CEM cells, a human T-cell line, albeit in low amounts, where it provides an important first line of defense against oxidant stress. 137 In the hibernation arousal of Syrian hamsters, examination of serum showed that EC-SOD and extracellular Cat increased while GPx decreased, indicating a protective role of extracellular Cat in hibernating animals. 120, 138 Tissues from a Cat knockout mouse showed reduced rates of eliminating extracellular H2O2, 139 providing additional evidence that intracellular antioxidants can modulate levels of extracellular ROS. In addition, chondrocytes incubated with extracellular Cat have been shown to increase COX-2, IL-8, and stromelysin expression, and a similar induction occurred with horseradish peroxidase, suggesting this activity is linked to a peroxidative signaling role for Cat. 140 In cell culture, exogenous Cat has been shown to prevent cellular proliferation by scavenging H2O2 and downregulating growth signals, while, at the same time, Cat treatment induced certain stress-related signals. 141 Similarly, overexpression of Cat in HP100 cells, a human leukemia cell line, was shown to promote H2O2 resistance. 142 
Peroxiredoxins (Prx)
The Prx are a novel antioxidant family of peroxidases that are also important in protecting the cell from ROS. Importantly, Prx reduce a wide range of hydroperoxides. Prx have also been referred to as Trx peroxidase (TPx) because Trx serves as an electron donor to reduce oxidized forms of the protein back to the active form. 4 Some plant forms of Prx may use Grx as an electron donor, 143 whereas GSH may also serve as an electron donor for mammalian Prx.
Many mammalian Prx isoforms exist: 15 have been reported, overall, with the human family comprising 6 members. 144, 145 Prx I, II, and VI are all located in the cytosol, whereas Prx III is found in mitochondria, and Prx V in the mitochondria and cytosol. Prx IV is the only known form located in the extracellular space; however, its expression is not uniform in all mammalian species. Although Prx IV has been localized predominantly to the cytoplasm, its aminoterminal domain has a signal peptide with cleavage sites that indicate its role as a secreted protein. In addition, Prx II, a known cytoplasmic form, has also been found in the plasma of multiple sclerosis patients with severe acute respiratory syndrome; T cells may be a source of secreted Prx II in plasma. 146 Another study also found Prx II in plasma and demonstrated it to be an interaction partner of Trx1. 147 Mouse Prx IV, which contains a signal peptide similar to that of human Prx IV, is apparently not secreted and appears to be a cytoplasmic signaling protein, 148 whereas rat Prx IV appears to function as a secreted protein. 149 Human Prx IV was first identified by yeast 2-hybrid screening as a partner for the thiol-specific antioxidant Pag; 150 it is a protein of a molecular mass of 31 kDa. A 27-kDa form of Prx IV has also been identified in many tissues, and both the 27-kDa and 31-kDa protein forms have been found in the testis. 151, 152 Along with their peroxidase functions, various members of the Prx family manifest a range of potential functions, from the role of Prx I in cell proliferation and apoptosis to the roles of other Prx as tumor suppressors 153, 154 and regulators of differentiation and gene expression. 4 In general, Prx are responsible for the elimination of H2O2 at low concentrations (ie, less than approximately 20 mol/L), are regulated by post-translational modification, and undergo irreversible oxidation of active site thiols by H2O2 at concentrations exceeding 20 mol/L. Prx I and Prx II are known to be regulated by phosphorylation, and Prx I-IV undergo reversible oxidation of the active site cysteine to sulfinic acid, which is then reversed by sulfiredoxin. 155, 156 All Prx contain a Cys residue in the aminoterminal region of the protein, and can, thus, be further divided into the subgroups 1-Cys, 2-Cys, and atypical 2-Cys. This nosology refers to the number of reactive Cys residues important for the catalysis of peroxidases. Of the 6 mammalian Prx, I-IV belong to the 2-Cys subgroup, Prx V to the atypical 2-Cys subgroup, and Prx VI to the 1-Cys subgroup. 145 The enzyme action requires a 2-step catalytic cycle in which the peroxide attacks a Cys, leading to its oxidation to sulfenic acid, followed by a second step in which the oxidized cysteine is "resolved".
In 1-Cys reactions, the oxidized Cys does not form a disulfide bond. In the 2-Cys reactions, a second Cys within the other subunit of a homodimer forms a disulfide bridge with the (oxidized) first Cys. In the atypical 2 Cys reactions, a disulfide bridge forms with another Cys on the same protein subunit. The disulfides are reduced by Trx, 143 and in 1-Cys reactions, GSH may also serve as an electron donor. 157 In the 2-Cys class of Prx, Cys that become further oxidized to sulfinic acid can be reduced by sulfiredoxin. 158 Trx and Grx have also been shown to be electron donors for sulfiredoxin in reversing the oxidation of Prxs in yeast. 156 Other modifications, such as glutathiolation, can protect Prxs from over-oxidation. 63, 143 Convincing evidence of the antioxidant properties and function of the secretable Prx IV in the extracellular space was shown by Okado-Matsumoto et al. 151 They confirmed that a 27-kDa form of Prx IV is secreted, can exist as both reduced and oxidized species, and is enzymatically active in the extracellular space. Prx IV is thought to bind to heparan sulfate on the surface of cells, as evidenced by the binding of 27-kDa and 31-kDa forms of Prx IV to heparinSepharose. Heparin binding is reversible and dependent on the redox state of Prx as treatment with dithiothreitol promoted heparin binding whereas diamide, which oxidizes Cys, prevented binding. 151 Other studies showed that Prx IV is a peroxidase that reduces both H2O2 and cumene hydroperoxide using either GSH or Trx as reductants.
Paraoxonase (PON)
PON 55 is an important extracellular antioxidant enzyme that may have a role in the prevention of atherogenesis. [159] [160] [161] [162] It is a 45-kDa serum protein 163 found at a serum concentration of 110 g/ml. 164 The 3 human PON enzymes, PON I, PON II, and PON III, are lactonases or lactonizing enzymes. 165 The genes encoding the 3 human PONs are homologous to each other; however, the exact function of each protein product is not yet known. 166 PON I is the best studied PON and is secreted in the blood 167 where it is thought to prevent oxidization of LDL; yet, the protective enzymatic function of PON I can be inactivated by oxidized LDL. 168 PON III has also been found in serum where it is associated with high-density lipoprotein (HDL). 169 PON I can also associate with HDL.
In contrast to PON I and PON III, PON II is not known to be associated with HDL, and its antioxidant function may be primarily intracellular. In vitro, PON II prevented LDL oxidation similar to PONI and PON III. PON III, like PON I and PON II, also protects against LDL oxidation, but PON III activity doubled the lag time for conjugated diene formation, is much more efficient than PON I in protecting against copper-induced LDL oxidation, and does not react with unsubstituted lactones or 4-or 7-member ring lactones. 170 It is thought that PON I and PON III may contribute to the function of HDL by preventing oxidative modification. HDL, an atheroprotective lipoprotein, contains 2 apolipoproteins, Apo AI and Apo AII. Both are important for lipid uptake, cholesterol efflux, and inhibition of the activity of hepatic lipase. 171 Lipidated ApoA1, but not lipid-free ApoAI, has been shown to be required for PON activity, suggesting that the lipid environment of HDL may enhance PON's activity. 172 While as an antioxidant, HDL, along with PON, inhibits both phospholipid oxidation and LDL oxidation; however, HDL may also increase lipid peroxide formation. 173 Other studies suggest that PON and HDL together have a protective role. Aviram et al showed that PON I is able to decrease oxidized lipids from human atherosclerotic lesions. 174 Studies of polymorphic forms of PON I, differing by a glutamine (Q) or arginine (R) at position 192, showed that PON IQ was more effective at decreasing lipid peroxides from atherosclerotic lesions of coronary and carotid arteries in in-vitro studies than was PON IR. In those experiments, PON I's effect on reducing lesion cholesteryl ester hydroperoxide content was found to depend on esterase and peroxidase-like activities. 174 Additional studies showed that PON I also reduces homocysteine thiolactone in human blood, while an increase in homocysteine levels lowers PON I activity. 175 Transgenic and knockout studies show that PON I deficiency results in oxidative stress in macrophages, as well as in serum, [176] [177] [178] suggesting a protective effect for this enzyme. Both HDL and PON are also found in the interstitial fluid where they can exert their antioxidant effects. 164 Decreased PON levels have also been shown to be associated with liver disease, asthma, and type 2 diabetes mellitus. [179] [180] [181] Other studies have focused on whether polymorphisms in the PON genes may predispose to stroke. PON promoter and coding region polymorphisms were shown to be associated with increased stroke and coronary artery disease risk in several studies, 175, [182] [183] [184] but a recent study of the polymorphisms in PON I, PON II, and PON III in ischemic stroke patients showed no association with an increased risk of ischemic stroke. 185 
Expression of Selenoproteins in Plasma
Selenium is an essential trace element with important health benefits. Inorganic forms include sodium selenide, sodium selenate, and sodium selenite, while organic forms exist as selenomethionine and selenocysteine. Selenium's multiple oxidation states of +4, +6, and -2 make it a highly oxidizable element with low oxidizing potential. 186 In order to be incorporated into protein, inorganic sodium selenite is first converted to an organic form, hydrogen selenide, by selenodiglutathione, GSSeSG, in a reaction that involves reduction by thiols and an NADPH-dependent reductase. Hydrogen selenide then becomes activated to selenophosphate by selenophosphate synthetase (Sel D). 187, 188 Selenocysteine synthesis is completed on a specific tRNA (tRNA sec ), which is charged with a serine that combines with selenophosphate to produce selenocysteine (Fig 1) .
Most selenium is associated with proteins as selenocysteine (Sec) in selenoproteins. Selenium is required for the proper function of selenoproteins (ie, Sel P and GPx), and their synthesis is reduced when selenium is limited. Extreme selenium deficiency results in Keshan disease, as seen in populations living in areas with selenium-poor soil in China; it is characterized by a cardiomyopathy that responds to treatment with selenium. Selenium deficiency also results in Kashan-Beck disease, which is characterized by osteoarthritis, and can contribute to impaired immune function, cardiovascular disease, cancer, AIDS, and inflammatory diseases. 189 Selenoprotein expression is complex and requires specific translational cofactors, including a specific tRNA Sec , an elonglation factor (EF Sec ), as well as a SECIS binding protein SBP2, Sel D, and adequate organified selenium. The UGA codon, typically known as a stop (opal) codon, is the codon for Sec in selenoproteins. Translation of selenoproteins requires a motif called a SECIS in the 3' untranslated region of selenoprotein transcripts. The SECIS element is necessary for selenocysteine incorporation and allows for UGA translational read-through; 190, 191 insufficient translational cofactors or selenium limitation results in premature termination of translation.
Additional translational factors of the Sec incorporation machinery influence selenoprotein synthesis. Recently discovered cofactors include the ribosomal protein L30, a SECIS binding protein that associates with ribosomes and SBP2 and then is exchanged for SBP2; the resulting conformational change in the SECIS triggers the release of Sec-tRNA sec and GTP hydrolysis. 192 Nuclease sensitive element binding protein 1 is another protein recently found to be an authentic SECIS-binding protein that is structurally associated with the selenoprotein translation complex. 193 In the absence of selenium, selenoprotein mRNAs are susceptible to nonsense-mediated decay, because the UGA may function like a premature stop codon. One recent study showed that nucleo-cytoplasmic shuttling of SBP2 and EF sec may be important for selenoprotein synthesis. 194 Specifically, assembly of these translational cofactors at the SECIS element during early mRNA synthesis may prevent nonsense-mediated decay, allowing recoding of the UGA stop codon and selenoprotein synthesis.
The unique nature of selenoprotein translation renders regulation of its expression difficult and may account for the inefficiency of selenocysteine incorporation. [195] [196] [197] In fact, a study by Mehta et al demonstrated that Sec incorporation efficiency in an in-vitro luciferase reporter system is only approximately 5-8% the levels of the wild-type luciferase. 198 
Selenoprotein P (Sel P)
Sel P and extracellular GSH peroxidase, GPx-3, are major selenium-containing proteins found in plasma. [199] [200] [201] [202] Sel P has heparin-binding properties, carries approximately 60% of plasma selenium, is expressed in the liver, and has up to 10 selenocysteine residues in the full-length form. 200, 203, 204 Plasma levels are approximately 5-6 mg/L. 205 Several isoforms of Sel P exist, including truncated forms at specific selenocysteine codons recognized as stop codons; 200, 206 however, the majority of Sel P purified from human plasma corresponded to 2 molecular masses, 55 and 61 kDa, on SDS-PAGE, 207 although the precise function of each of the isoforms remains unknown.
Although the function of Sel P is unknown, it is thought to act as a selenium transporter 208, 209 or possibly as an antioxidant. 210 There is much evidence demonstrating the role of Sel P as a transport protein; this concept has, however, been disputed. Theoretically, if Sel P was a source of cellular selenium, it would need to undergo a digestion step to liberate the selenium, 201, 211 suggesting a complex and metabolically costly means of regulating selenium availability.
Experimentially, Sel P appears to be an important source of selenium for cultured cells and tissues. Cells cultured with Sel P-depleted serum have decreased activities of intracellular selenium-dependent enzymes GPx1, phospholipid GPx, and TrxR, as well as a decrease in the overall selenium content of the cells, compared with control cells cultured with Sel P-containing serum, suggesting that Sel P can function as a source for cellular selenium. 211 Other studies demonstrated disrupted selenium distribution and enzymatic activities in the plasma, brain, testis, and kidney of Sel P -/-mice. In those mice, the liver, as the main source of Sel P expression, had an increase in selenium accumulation, 212 suggesting a role for selenoproteins synthesized in the liver as source of selenium for other tissues. Sel P -/-mice also had reduced whole-body selenium, 213 while mice expressing Sel P with a carboxyterminal deletion had reduced selenium only in brain and testis. A study by Schweizer et al showed that Sel P is important for development, because Sel P -/-mice have severe growth defects and poor motor coordination. Sodium selenite supplementation in lactating dams can overcome selenium deficiency in developing Sel P -/-pups and rescue growth defects and poor motor coordination. Interestingly, extracellular GPx-3 levels were also decreased by Sel P deficiency. 215 Those data confirm earlier studies that used radiolabeled selenium to follow selenium incorporation in various selenoproteins, showing that plasma levels of radiolabeled Sel P temporally preceded the appearance of radiolabeled GPx-3. 216 Aside from its potential role as a transport protein, another potential role of Sel P is that of an antioxidant protein. Not only is Sel P expressed in the liver, brain, and kidney, but it has also been shown to be associated with endothelial cells and was found to be secreted from bovine aortic endothelial cells. 217, 218 Other studies, however, suggest that endothelial cells do not make Sel P, because it was not secreted from human umbilical-vein endothelial cells. 219 Exogenous Sel P has also been shown to protect human astrocytes and endothelial cells from oxidative damage. 220, 221 Other evidence for its role as an ROS scavenger comes from a study showing that Sel P can reduce phospholipd hydroperoxides, but not H2O2 or tert-butyl hydroperoxides. 222 A subsequent study by Takebe et al demonstrated that Trx may be the preferred reducing donor for Sel P. 223 
Plasma GSH Peroxidase (GPx-3)
GPx-3, is a selenocysteine-containing enzyme with antioxidant properties. It is a member of the family of selenocysteine-containing GSH peroxidase enzymes of which there are 5 forms: cellular or classical GPx (cGPx or GPx-1), gastrointestinal GPx (GI-GPx or GPx-2), plasma GPx (pGPx or GPx-3), phospholipid GPx (PHGPx or GPx-4), and sperm nuclei GPx (snGPx). Like other members of the GPx family, it catalyzes the reduction of H2O2 and lipid hydroperoxides, using GSH as a reducing agent. However, GPx-3 has a comparatively low specific enzyme activity (2GSH + ROOH GSSG + H2O + ROH) 224 and, compared with GPx-1, GPx-3 has an approximately 10-fold higher Km for GSH. Plasma concentrations of GSH are 1/1,000 th that of cytosol, suggesting GSH may not be the preferred electron donor for GPx-3 in plasma. In vitro experiments suggest Trx and Grx can function as electron donors for GPx-3. 74 Interestingly, it has also been suggested that nonmammalian CysGPx, those that have a cysteine instead of a selenocysteine at their active sites, have TPx activity. This was demonstrated in a study in which Drosophila melanogaster GPx was found to have peroxidase activity that was 2 orders of magnitude higher in the presence of Trx as a cosubstrate compared with GSH. 225 To date, the precise mechanism of action of GPx-3 and its reductive cofactor(s) in the extracellular space are unclear.
The GPx-3 gene is composed of 5 exons located on chromosome 5q32 spanning approximately 10 kb. 226 GPx-3 is a 23-kDa homotetramer and glycoprotein present in extracellular fluids. [227] [228] [229] It is expressed in various tissues, with the highest mRNA levels in kidney where it is principally secreted by the renal proximal tubular cells. 230, 231 An increase in GPx-3 in plasma has been shown to correlate with increased mRNA in the kidney. 232 Plasma levels are approximately 24.2 mg/L. 233 GPx-3 has also been detected in milk, 234 adipose tissue, 235 lung 236 and intestine. 237 In studying the expression of human GPx-3, our group identified a novel transcription start site 233 bp downstream of the previously published start site, demonstrated that the GPx-3 promoter is regulated by hypoxia, and showed that cotransfection of selenoprotein-specific translational cofactors increased GPx-3 expression in cultured cells. 238 In a subsequent study of children and young adults with ischemic stroke, we found that polymorphisms in the GPx-3 promoter, at -942, -927, -861, -568, -518, -302 -284, and -65 upstream of the transcription start site, were strongly linked and formed 2 novel haplotypes. The less common haplotype (H2) had reduced GPx-3 transcriptional activity in a reporter gene assay, and was significantly more prevalent among stroke patients than controls, suggesting a link between the GPx-3 promoter polymorphisms and the risk for arterial ischemic stroke in the young. 239 GPx-3 has been proposed as a major scavenger of ROS in plasma, thus maintaining NO bioavailability and an antithrombotic environment in the vasculature. 240 Its deficiency may lead to platelet activation and a prothrombotic state and predispose to arterial thrombotic disease. In vitro platelet studies showed that platelet aggregation could be attenuated by GPx with S-nitroso-GSH (SNO-Glu), a NO donor, and not with SNO-Glu alone. 241 In another study, Freedman et al compared GPx-3 activities in 2 brothers with childhood stroke to subjects with no history of stroke, 240 and demonstrated that both brothers had a reduction in GPx-3 activity, as well as having hyperactive platelets. In those individuals, inhibition of platelet activity by NO was impaired. In additional family studies examining 7 pedigrees of familial childhood stroke, 3 of the 7 families had reduced GPx-3 activity in probands and parents. 242 The biological role of GPx-3 is still unclear. Mirochnitchenko et al demonstrated a role for GPx-3 in endotoxemia and inflammation. Specifically, mice overexpressing GPx-3 have decreased plasma nitrate/nitrite levels, increased production of NO, decreased lipid peroxides, and modulated cytokine production following lipopolysaccharide treatment, compared with controls. 243 The same group showed that mice overexpressing GPx-3 manifest better control of peroxide levels under high body temperatures when compared with control mice, 244 thus indicating an antioxidant protective action for GPx-3.
Thioredoxin Reductase (TrxR)
TrxR is a member of the nucleotide-disulfide oxidoreductase family. These proteins are homodimeric flavoenzymes with 1 flavin adenine dinucleotide and 1 NADPH binding domain per unit, and a selenocysteine located at the penultimate carboxyterminal amino acid. 109, 228 TrxR catalyzes the NADPH-dependent reduction of oxidized Trx 228 and exhibits broad substrate specificity, which may possibly be related to the location of the Sec in the carboxyterminal of the protein, 109, [245] [246] [247] [248] [249] [250] allowing for a more accessible and less constrained active site conformation for its substrates. Identification of a selenosulfide at the active site of TrxR supports a role in peroxide reduction. 251 TrxR is involved in a variety of functions, such as intracellular signal transduction, gene expression, and cell proliferation. 252 TrxR has also been suggested to play a role extracellularly 253, 254 and some of its substrates include Trx, selenite, and lipoic acid. 87, 109, 255 Three known forms of TrxR exist: TrxR1, a cytosolic enzyme; TrxR2, a mitochondrial enzyme; and TrxR3, originally purified from mouse testis. TrxR apparently exists as 108-116 kDa homodimers, with monomeric units of 54-Circulation Journal Vol.72, January 2008 58 kDa. Recently, a new member of the TrxR family has been identified, a mammalian Trx/GSH reductase, which is a fusion of an aminoterminal Grx domain and a TrxR sequence, and is involved in disulfide bond isomerization. 256, 257 An extracellular TrxR form of 116 kDa was found to be secreted from peripheral blood mononuclear cells and monocytes, 258 and secretion of TrxR has also been demonstrated in leukemia and melanoma cell lines; 253 however, the exact function of these secreted TrxR isoforms is unclear. Soderberg et al showed that release of TrxR from cells follows the classical Golgi pathway. Its median plasma concentration is approximately 18 ng/ml. 253 Considered primarily as an antioxidant, the exact role of extracellular TrxR remains unknown, but it has been suggested that it may play a role in cell growth, apoptosis, transcription, and DNA synthesis. 109 
Conclusions
Extracellular antioxidant systems serve an important protective and preventive role in mammals. They function to eliminate ROS and RNS, and to prevent lipid peroxidation and protein oxidation. Extracellular antioxidants work in concert with intracellular antioxidants to control both the influx and efflux of H2O2 and O2 -that may serve to modulate redox signaling or to perturb normal cellular processes (Fig 2) . Understanding the roles of and crosstalk between extracellular and intracellular antioxidants will help us further understand their impact on physiological and pathological conditions. Cat, catalase; Cys, cysteine; Cyss, cystine; EC, extracellular; GPx, glutathione peroxidase; HDL, high-density lipoprotein; LDL, low-density lipoprotein; NADPH, nicotinamide adenine dinucleotide phosphate; PON, paraoxonase; Prx, peroxiredoxin; Sel P, selenoprotein P; SOD, superoxide dismutase.
